• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗性干细胞移植的免疫障碍。

Immunologic hurdles of therapeutic stem cell transplantation.

机构信息

Institute for Medical Microbiology, Immunology and Hygiene, Medical Center, University of Cologne, D-50935 Cologne, Germany.

出版信息

Biol Chem. 2009 Oct;390(10):977-83. doi: 10.1515/BC.2009.114.

DOI:10.1515/BC.2009.114
PMID:19642871
Abstract

Detailed knowledge of the immunologic properties of embryonic stem (ES) cells is a prerequisite for safe applications of ES cell-based regenerative medicine. Recently, the long-standing assumption that ES cells are ignored by immunocompetent hosts was disproved. Instead, it is becoming increasingly clear that ES cells actively protect themselves via several immunomodulatory and immunoevasive mechanisms against cytotoxic T-lymphocytes and natural killer cells. Here we review current knowledge about the immunologic properties of ES cells and discuss the implications for ES cell-based regenerative medicine, for the immunobiology of the embryo as a semi-allogeneic graft, and for the regenerative capacity of adult stem cells.

摘要

详细了解胚胎干细胞(ES 细胞)的免疫学特性是安全应用基于 ES 细胞的再生医学的前提。最近,长期以来的假设即 ES 细胞被免疫宿主忽略的观点被推翻。相反,越来越清楚的是,ES 细胞通过几种免疫调节和免疫逃避机制主动保护自己免受细胞毒性 T 淋巴细胞和自然杀伤细胞的侵害。本文综述了 ES 细胞免疫学特性的最新知识,并讨论了其对基于 ES 细胞的再生医学、胚胎作为半同种异体移植物的免疫生物学以及成年干细胞的再生能力的影响。

相似文献

1
Immunologic hurdles of therapeutic stem cell transplantation.治疗性干细胞移植的免疫障碍。
Biol Chem. 2009 Oct;390(10):977-83. doi: 10.1515/BC.2009.114.
2
Stretching the limits: stem cells in regeneration science.突破极限:再生科学中的干细胞
Dev Dyn. 2008 Dec;237(12):3648-71. doi: 10.1002/dvdy.21774.
3
Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells?脊髓损伤干细胞治疗的挑战:人胚胎干细胞、内源性神经干细胞还是诱导多能干细胞?
Stem Cells. 2010 Jan;28(1):93-9. doi: 10.1002/stem.253.
4
Embryonic and adult stem cell therapy.胚胎和成体干细胞治疗。
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S336-44. doi: 10.1016/j.jaci.2009.09.032. Epub 2010 Jan 12.
5
A dive into the stem cells world.深入干细胞世界。
Panminerva Med. 2009 Mar;51(1):1-3.
6
Survival of priceless cells: active and passive protection of embryonic stem cells against immune destruction.
Arch Biochem Biophys. 2007 Jun 15;462(2):273-7. doi: 10.1016/j.abb.2007.03.032. Epub 2007 Apr 10.
7
The use of stem cells in kidney disease.干细胞在肾脏疾病中的应用。
Curr Opin Organ Transplant. 2009 Feb;14(1):72-8. doi: 10.1097/MOT.0b013e328320d2f5.
8
Very small embryonic-like stem cells for regenerative medicine: WO2010039241.用于再生医学的非常小的胚胎样干细胞:WO2010039241。
Expert Opin Ther Pat. 2010 Aug;20(8):1103-6. doi: 10.1517/13543776.2010.495122.
9
When stem cells meet immunoregulation.当干细胞遇到免疫调节。
Int Immunopharmacol. 2009 May;9(5):596-8. doi: 10.1016/j.intimp.2009.01.014. Epub 2009 Jan 29.
10
Embryonic and adult stem cell systems in mammals: ontology and regulation.哺乳动物的胚胎和成人干细胞系统:本体论和调控。
Dev Growth Differ. 2010 Jan;52(1):115-29. doi: 10.1111/j.1440-169X.2009.01160.x.

引用本文的文献

1
Enhancing RPE Cell-Based Therapy Outcomes for AMD: The Role of Bruch's Membrane.增强基于视网膜色素上皮细胞的年龄相关性黄斑变性治疗效果:布鲁赫膜的作用。
Transl Vis Sci Technol. 2014 Jul 3;3(3):11. doi: 10.1167/tvst.3.3.11. eCollection 2014 Jun.
2
Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: improved survival when implanted as a monolayer.人胚胎干细胞来源的视网膜色素上皮细胞的视网膜下植入:单层植入时存活率提高。
Invest Ophthalmol Vis Sci. 2013 Jul 26;54(7):5087-96. doi: 10.1167/iovs.12-11239.
3
Immunogenicity of in vitro maintained and matured populations: potential barriers to engraftment of human pluripotent stem cell derivatives.
体外维持和成熟群体的免疫原性:人类多能干细胞衍生物植入的潜在障碍。
Methods Mol Biol. 2013;1029:17-31. doi: 10.1007/978-1-62703-478-4_2.
4
Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations.利用多能细胞衍生物进行治疗的潜在障碍:体外维持和成熟群体的固有免疫原性。
Semin Immunopathol. 2011 Nov;33(6):563-72. doi: 10.1007/s00281-011-0269-5. Epub 2011 Apr 11.
5
Effects of histocompatibility and host immune responses on the tumorigenicity of pluripotent stem cells.多能干细胞的组织相容性和宿主免疫反应对其致瘤性的影响。
Semin Immunopathol. 2011 Nov;33(6):573-91. doi: 10.1007/s00281-011-0266-8. Epub 2011 Apr 4.
6
How to cross immunogenetic hurdles to human embryonic stem cell transplantation.如何跨越免疫遗传学障碍进行人胚胎干细胞移植。
Semin Immunopathol. 2011 Nov;33(6):525-34. doi: 10.1007/s00281-011-0262-z. Epub 2011 Apr 2.